Tag

The panel will address the rationale, planning and structuring of a going private transaction, including transaction structures, securities regulations, disclosure and filing requirements, timelines and litigation mitigation strategies.

After a brief slowdown in 2021, shareholder activism has made a strong resurgence in 2022-23, with many new players and increased investments opportunities driven by depressed equity values. The panel will discuss the regulatory environment, SEC rules and regulations, universal...

The panel will discuss anticipated M&A activity in 2023, including most active industries and geographies.  We will address deal drivers, transaction structures, due diligence, ESG, private equity investor strategies and answer questions from the audience. This program is...

M&A activity is still significantly above pre-pandemic levels, with healthcare remaining one of the most active industries transactionally. The panel will discuss M&A trends by healthcare verticals, labor and supply chain shortages, financing availability, valuations and...

The panel will discuss cross-border M&A trends in the face of current geopolitical and financial turbulence, including the after-effects of the Pandemic, Russia-Ukraine war, and China’s economic threat. We will address transactional opportunities and structures, due diligence...

With the disruptions of the pandemic largely behind us, multinationals and private equity investors are targeting Latin America company acquisitions to leverage natural resource availability, lower labor costs and expanding consumer market demand. The panel will discuss current...

REGISTER COMPLIMENTARY / SUBMIT QUESTIONS TO THE PANEL HERE

WATCH THE REPLAY Our panel of experts will discuss disclosure, regulatory and accounting considerations, as well as internal controls and corporate governance issues relevant to SPACs. We will also address areas of potential liability to SPACs sponsors, targets and their...